Salmeterol reduces the need for inhaled corticosteroid in steroid-dependent asthmatics

Previous results have demonstrated addition of long-acting β 2-adrenergic agonists to be beneficial in asthma patients already receiving inhaled corticosteroid. The purpose of this study was to determine, qualitatively as well as quantitatively, the steroid-sparing properties of salmeterol in stable...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Respiratory medicine 1999-12, Vol.93 (12), p.863-868
Hauptverfasser:	Nielsen, L.P., Pedersen, B., Faurschou, P., Madsen, F., Wilcke, J.T.R., Dahl, R.
Format:	Artikel
Sprache:	eng
Schlagworte:	Administration, Inhalation Adrenergic beta-Agonists - therapeutic use Adult Aged Albuterol - analogs & derivatives Albuterol - therapeutic use Anti-Asthmatic Agents - therapeutic use Asthma - drug therapy Asthma - physiopathology Beclomethasone - administration & dosage Biological and medical sciences Bronchodilator Agents - therapeutic use Double-Blind Method Female Forced Expiratory Volume Glucocorticoids - administration & dosage Humans Male Medical sciences Middle Aged Peak Expiratory Flow Rate Pharmacology. Drug treatments Respiratory system Salmeterol Xinafoate
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!